PT  - JOURNAL ARTICLE
AU  - Anthony R. Ives
AU  - Claudio Bozzuto
TI  - Estimating and explaining the spread of COVID-19 at the county level in the USA
AID  - 10.1101/2020.06.18.20134700
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.18.20134700
4099  - http://medrxiv.org/content/early/2020/10/25/2020.06.18.20134700.short
4100  - http://medrxiv.org/content/early/2020/10/25/2020.06.18.20134700.full
AB  - The basic reproduction number, R0, determines the rate of spread of a communicable disease and therefore gives fundamental information needed to plan public health interventions. Using mortality records, we estimated the rate of spread of COVID-19 among 160 counties and county-aggregates in the USA. Here, we show that most of the high among-county variance is explainable by four factors (R2 = 0.70): the timing of outbreak, population size, population density, and spatial location. For predictions of future spread, population density and spatial location are important, and for the latter we show that SARS-CoV-2 strains containing the G614 mutation to the spike gene are associated with higher rates of spread. Finally, the high predictability of R0 allows extending estimates to all 3109 counties in the conterminous 48 states. The high variation of R0 argues for public health policies enacted at the county level for controlling COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://github.com/nytimes/covid-19-dataFunding StatementThis work was supported by NASA-AIST-80NSSC20K0282 (A.R.I).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research involves only public data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code have been uploaded with an earlier version of this manuscript.